NEU 1.74% $15.21 neuren pharmaceuticals limited

Neurogene for Rett, page-12

  1. 793 Posts.
    lightbulb Created with Sketch. 155
    I agree with Pilcher. My issue with gene therapy is that you play with a gene then potentially cause a serious issue in another 10, 20, 40 + years... who knows when. Its a long time to follow up to determine a safety profile.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.